Where are oncofertility and fertility preservation treatments heading in 2016?

Miyuki Harada1, Yutaka Osuga1

  • 1Department of Obstetrics & Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo, 113-8655, Japan.

Insights

Cancer survival is up, boosting fertility preservation needs. This review examines current options and future fertility preservation strategies, highlighting evidence limitations.

Area of Science:

  • Reproductive Medicine
  • Oncology
  • Cell Biology

Background:

  • Improved cancer survival rates increase the need for fertility preservation.
  • Advancements in assisted reproductive technologies support oncofertility.
  • Fertility preservation is crucial for cancer patients of reproductive age.

Purpose of the Study:

  • To review current fertility preservation methods for cancer patients.
  • To discuss limitations and evidence gaps in existing strategies.
  • To propose future directions for oncofertility research and treatment.

Main Methods:

  • Literature review of oncofertility and fertility preservation.
  • Analysis of available and emerging fertility preservation techniques.
  • Discussion of clinical concerns and future research needs.

Main Results:

  • Several fertility preservation options exist, but evidence is limited for each.
  • Current methods include oocyte, embryo, and ovarian tissue cryopreservation.
  • Emerging techniques show promise but require further validation.

Conclusions:

  • Fertility preservation is advancing, but evidence gaps remain a concern.
  • Further research is needed to validate emerging oncofertility strategies.
  • Future approaches may offer improved options for cancer patients.

Related Concept Videos

Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
5.0K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
657
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K